Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 7

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 7
---
 compliance with NASDAQ’s minimum bid price per share requirement, we effected
a ratio change in the number of Ordinary Shares represented by our Depositary Shares from 400 Ordinary Shares per Depositary Share to
10,000 Ordinary Shares per Depositary Share. No fractional Depositary Shares were issued.

On November 22, 2024,
we held a general meeting of shareholders, or November GM, and our shareholders passed resolutions to (i) subdivide our Ordinary Shares
of £0.001 nominal value each into one ordinary share of £0.00005 nominal value and 19 C deferred shares of £0.00005
nominal value each, each the November Subdivision, and (y) adopt new Articles of Association, which made consequential amendments to
the existing Articles of Association of the Company to reflect the November Subdivision. As is standard for deferred shares, each C deferred
share has very limited rights and is effectively valueless. The C deferred shares have the rights and restrictions as set out in the
Articles of Association and do not entitle the holder thereof to receive notice of or attend and vote at any general meeting of the Company
or to receive a dividend or other distribution.

| 2 |

On June 11, 2025, we
held a general meeting of shareholders, or June 2025 GM, and our shareholders passed resolutions to (i) subdivide our Ordinary Shares
of £0.00005 nominal value each into one ordinary share of £0.000001 nominal value and 49 D deferred shares of £0.000001
nominal value each, each the June 2025 Subdivision, and (y) adopt new Articles of Association, which made consequential amendments to
the existing Articles of Association of the Company to reflect the June Subdivision. As is standard for deferred shares, each D deferred
share has very limited rights and is effectively valueless. The D deferred shares have the rights and restrictions as set out in the
Articles of Association and do not entitle the holder thereof to receive notice of or attend and vote at any general meeting of the Company
or to receive a dividend or other distribution.

On July 31, 2025, we
effected a ratio change in the number of Ordinary Shares represented by our Depositary Shares from 10,000 Ordinary Shares per Depositary
Share to 100,000 Ordinary Shares per Depositary Share. No fractional Depositary Shares were issued.

The change in the number
of Ordinary Shares resulting from the reverse